• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

小分子AMPK直接激动剂的最新研究进展

魏强强, 段文虎, 周金培, 张惠斌

魏强强, 段文虎, 周金培, 张惠斌. 小分子AMPK直接激动剂的最新研究进展[J]. 中国药科大学学报, 2015, 46(4): 406-415. DOI: 10.11665/j.issn.1000-5048.20150404
引用本文: 魏强强, 段文虎, 周金培, 张惠斌. 小分子AMPK直接激动剂的最新研究进展[J]. 中国药科大学学报, 2015, 46(4): 406-415. DOI: 10.11665/j.issn.1000-5048.20150404
WEI Qiangqiang, DUAN Wenhu, ZHOU Jinpei, ZHANG Huibin. Recent research progress in small molecule AMPK direct activators[J]. Journal of China Pharmaceutical University, 2015, 46(4): 406-415. DOI: 10.11665/j.issn.1000-5048.20150404
Citation: WEI Qiangqiang, DUAN Wenhu, ZHOU Jinpei, ZHANG Huibin. Recent research progress in small molecule AMPK direct activators[J]. Journal of China Pharmaceutical University, 2015, 46(4): 406-415. DOI: 10.11665/j.issn.1000-5048.20150404

小分子AMPK直接激动剂的最新研究进展

Recent research progress in small molecule AMPK direct activators

  • 摘要: 2型糖尿病是一种慢性代谢性疾病,其主要表现为高血糖和微血管并发症,是影响人类生活的重大疾病之一,目前尚无理想的治疗药物。腺苷酸活化蛋白激酶(AMP-activated protein kinase,AMPK)是一种高度保守的丝氨酸/苏氨酸蛋白激酶,在细胞和机体能量代谢与平衡等方面发挥重要作用;小分子AMPK直接激动剂因在降低血糖方面的作用而有望成为新一代治疗2型糖尿病的药物。本文按结构分类,对近几年报道的小分子AMPK直接激动剂进行综述。
    Abstract: Type 2 diabetes, an epidemic disorder characterized by high blood glucose level associated with microvascular complications, is one of the main causes of human suffer across the globe, with no effective medicine up to now. AMP-activated protein kinase(AMPK), a highly conserved serine/threonine protein kinase, is a key sensor and regulator of intracellular and whole-body energy metabolism. Small molecule AMPK direct activators have been proven to lower blood-glucose, which is a promising candidate for the treatment of type 2 diabetes. The progress on the research of small molecule AMPK direct activators in recent years is summarized in this paper.
  • [1] Saltiel AR,Kahn CR.Insulin signaling and the regulation of glucose and lipid metabolism[J].Nature,2001,414(6865):799-806.
    [2] Nathan DM,Buse JB,Davidson MB,et al.Management of hyperglycemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy:a consensus statement from the American diabetes association and the European association for the study of diabetes[J].Diabetes Care,2006,29(8):1963-1972.
    [3] Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action[J].J Clin Investig,2001,108(8):1167-1174.
    [4] Scott JW,Ross FA,Liu JK,et al.Regulation of AMP-activated protein kinase by a pseudosubstrate sequence on the γ subunit[J].EMBO J,2007,26(3):806-815.
    [5] Viollet B,Lantier L,Devin-Leclerc J,et al.Targeting the AMPK pathway for the treatment of type 2 diabetes[J].Front Biosci,Landmark Ed.,2009,14(9):3380-3400.
    [6] Hardie DG,Hawley SA,Scott JW.AMP-activated protein kinase-development of the energy sensor concept[J].J Physiol,2006,574(Pt 1):7-15.
    [7] Rana S,Blowers EC,Natarajan A.Small molecule adenosine 5′-monophosphate activated protein kinase(AMPK)modulators and human diseases[J].J Med Chem,2015,58(1):2-29.
    [8] Schimmack G, Defronzo RA, Musi N. AMP-activated protein kinase:role in metabolism and therapeutic implications[J].Diabetes Obes Metab,2006,8(6):591-602.
    [9] Xiao B,Sanders MJ,Underwood E,et al.Structure of mammalian AMPK and its regulation by ADP[J].Nature,2011,472(7342):230-243.
    [10] Zhang BB,Zhou G,Li C.AMPK:an emerging drug target for diabetes and the metabolic syndrome[J].Cell Metab,2009,9(5):407-416.
    [11] Shaw RJ,Kosmatka M,Bardeesy N,et al.The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress[J].Proc Natl Acad Sci U S A,2004,101(10):3329-3335.
    [12] Xie M,Zhang D,Dyck JR,et al.A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway[J].Proc Natl Acad Sci U S A,2006,103(46):17378-17383.
    [13] Hardie DG.AMP-activated protein kinase as a drug target[J].Annu Rev Pharmacol Toxicol,2007,47:185-210.
    [14] Bergeron R,Previs SF,Cline GW,et al.Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese zucker rats[J].Diabetes,2001,50(5):1076-1082.
    [15] McGee SL,Hargreaves M.Exercise and skeletal muscle glucose transporter 4 expression:molecular mechanisms[J].Clin Exp Pharmacol Physiol,2006,33(4):395-399.
    [16] Foretz M, Ancellin N, Andreelli F, et al. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver[J].Diabetes,2005,54(5):1331-1339.
    [17] Kukidome D,Nishikawa T,Sonoda K,et al.Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells[J].Diabetes,2006,55(1):120-127.
    [18] Peabody RA,Goldthwait DA,Greenberg GR.The structure of glycinamide ribotide[J].J Biol Chem,1956,221:1071-1081.
    [19] Schnebli HP,Hill DL,Bennett LL,Jr.Purification and properties of adenosine kinase from human tumor cells of type HEp No.2[J].J Biol Chem,1967,242(9):1997-2004.
    [20] Henin N,Vincent MF,Van den Berghe G.Stimulation of rat liver AMP-activated protein kinase by AMP analogs[J].Biochim Biophys Acta Gen Subj,1996,1290(2):197-203.
    [21] Corton JM,Gillespie JG,Hardie DG.Role of the AMP-activated protein kinase in the cellular stress response[J].Curr Biol,1994,4(4):315-324.
    [22] Russell RR,Bergeron R,Shulman GI,et al.Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR[J].Am J Physiol,1999,277(Pt.2):H643-H649.
    [23] Hayashi T,Hirshman MF,Kurth EJ,et al.Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport[J].Diabetes,1998,47(8):1369-1373.
    [24] Cool B,Zinker B,Chiou W,et al.Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome[J].Cell Metab,2006,3(6):403-416.
    [25] Goeransson O,McBride A,Hawley SA,et al.Mechanism of action of A-769662,a valuable tool for activation of AMP-activated protein kinase[J].J Biol Chem,2007,282(45):32549-32560.
    [26] Xiao B,Sanders MJ,Carmena D,et al.Structural basis of AMPK regulation by small molecule activators[J].Nat Comm,2013,4(4017):1-10.
    [27] Mirguet O,Sautet S,Clement CA,et al.Discovery of pyridones as oral AMPK direct activators[J].ACS Med Chem Lett,2013,4(7):632-636.
    [28] Bouillot AMJ,Daugan ACM,Lamotte Y,et al.Preparation of 1H-pyrrolo[3,2-d] pyrimidinedione derivatives as activators of AMPK:US,2012119979A1[P].2012-09-13[2015-02-09] .
    [29] Bookser BC,Dang Q,Gibson TS,et al.Preparation of cyclic benzimidazole derivatives as activators of AMP-protein kinase useful anti-diabetic agents:US,2010036613A1[P].2010-04-01[2015-02-09] .
    [30] Bookser BC, Dang Q, Gibson TS, et al. Cyclic benzimidazole derivatives as AMP-protein kinase activators and their preparation,pharmaceutical compositions and use in the treatment of diseases:US,2010047982A1[P].2010-04-26[2015-02-09] .
    [31] Dang Q,Chung DM,Gibson TS,et al.Novel cyclic benzimidazole derivatives as AMP-activated protein kinase activators and anti-diabetic agents and their preparation:US,2010051176A1[P].2010-05-06[2015-02-09].
    [32] Dang Q,Chung DM,Gibson TS,et al.Novel cyclic benzimidazole derivatives as AMP-activated protein kinase activators and anti-diabetic agents and their preparation:US,2010051206A1[P].2010-05-06[2015-02-09].
    [33] Kojima E,Fujioka M.Benzimidazole or azabenzimidazole derivative having AMPK-activating effect,pharmaceutical composition containing it,and method prevention or treatment of diabetes mellitus:JP,2014069426A1[P].2014-03-15[2015-02-09].
    [34] Kojima E,Hinata Y,Tamura Y,et al.Preparation of 5-oxybenzimidazole and 5-oxyazabenzimidazole derivatives as AMPK activators:JP,2014175330A1[P].2014-10-03[2015-02-09].
    [35] Kojima E,Tonogaki K,Tanaka N,et al.Azabenzimidazole derivatives having AMPK-activating activity:JP,2013011932A1[P].2013-01-24[2015-02-09].
    [36] Tonogaki K,Ino A,Kojima E,et al.Preparation of hetero ring-fused imidazole derivatives as AMPK activators:JP,2012033149A1[P].2012-08-05[2015-02-09].
    [37] Bhattacharya SK,Cameron KOK,Dowling MS,et al.Preparation of indole and indazole compounds that activate AMPK:US,2014140704A1[P].2014-09-18[2015-02-09] .
    [38] Pang T, Zhang ZS, Gu M, et al. Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells[J].J Biol Chem,2008,283(23):16051-16060.
    [39] Yu LF,Li YY,Su MB,et al.Development of novel alkene oxindole derivatives as orally efficacious AMP-activated protein kinase activators[J].ACS Med Chem Lett,2013,4(5):475-480.
    [40] Li YY, Yu LF, Zhang LN, et al. Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice[J].Toxicol Appl Pharmacol,2013,273(2):325-334.
    [41] Anil TM,Harish C,Lakshmi MN,et al.CNX-012-570,a direct AMPK activator p
计量
  • 文章访问数: 
  • HTML全文浏览量:  0
  • PDF下载量: 
  • 被引次数: 0
出版历程
  • 刊出日期:  2015-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭